Severe Undifferentiated Vasoplegic Shock Refractory to Vasoactive Agents Treated with Methylene Blue
Methylene blue is a phenothiazine-related heterocyclic aromatic molecule presently used in the treatment of methemoglobinemia. Recently, it has been implicated in the treatment of severe refractory vasoplegic shock caused by anaphylaxis, sepsis, or postcardiopulmonary bypass. We present a case of a...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wiley
2017-01-01
|
| シリーズ: | Case Reports in Critical Care |
| オンライン･アクセス: | http://dx.doi.org/10.1155/2017/8747326 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|